Literature DB >> 16583223

[Neurophysiology of pruritus].

U Raap1, A Ikoma, A Kapp.   

Abstract

Neurophysiologic studies indicate that pruritus is a distinct sensation with its own neuronal pathways in the peripheral and central nervous system which are different from that of pain. Pruritus is a very disturbing sensation and most common skin-related symptom. Histamine was long considered to be the only mediator of pruritus. However, it has become evident that - besides histamine - a variety of neuromediators such as neurotrophins and neuropeptides as well as their receptors play an important role in pruritus. Neuromediators are produced by mast cells, keratinocytes and eosinophil granulocytes which are in close contact to sensory nerves. The discovery of these neurophysiological interactions opens new and promising therapeutic options for the treatment of pruritus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16583223     DOI: 10.1007/s00105-006-1125-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  36 in total

1.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism.

Authors:  M Steinhoff; N Vergnolle; S H Young; M Tognetto; S Amadesi; H S Ennes; M Trevisani; M D Hollenberg; J L Wallace; G H Caughey; S E Mitchell; L M Williams; P Geppetti; E A Mayer; N W Bunnett
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Brain activation by histamine prick test-induced itch.

Authors:  B Walter; M N Sadlo; J Kupfer; V Niemeier; B Brosig; R Stark; D Vaitl; U Gieler
Journal:  J Invest Dermatol       Date:  2005-08       Impact factor: 8.551

3.  Acetylcholine induces different cutaneous sensations in atopic and non-atopic subjects.

Authors:  M Vogelsang; G Heyer; O P Hornstein
Journal:  Acta Derm Venereol       Date:  1995-11       Impact factor: 4.437

4.  Effect of topical application of nerve-growth factor on pressure ulcers.

Authors:  R Bernabei; F Landi; S Bonini; G Onder; A Lambiase; R Pola; L Aloe
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

5.  Increase in NGF content and nerve fiber sprouting in human allergic contact eczema.

Authors:  I Kinkelin; S Mötzing; M Koltenzenburg; E B Bröcker
Journal:  Cell Tissue Res       Date:  2000-10       Impact factor: 5.249

6.  Electrically evoked itch in humans.

Authors:  Akihiko Ikoma; Hermann Handwerker; Yoshiki Miyachi; Martin Schmelz
Journal:  Pain       Date:  2005-01       Impact factor: 6.961

7.  Light and electron microscopic immunohistochemical observations of p75 nerve growth factor receptor-immunoreactive dermal nerves in prurigo nodularis.

Authors:  Y Liang; J A Marcusson; O Johansson
Journal:  Arch Dermatol Res       Date:  1999-01       Impact factor: 3.017

8.  Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1.

Authors:  David A Groneberg; Frauke Serowka; Nora Peckenschneider; Metin Artuc; Andreas Grützkau; Axel Fischer; Beate M Henz; Pia Welker
Journal:  J Neuroimmunol       Date:  2005-04       Impact factor: 3.478

9.  Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin.

Authors:  M Bigliardi-Qi; L T Sumanovski; S Büchner; T Rufli; P L Bigliardi
Journal:  Dermatology       Date:  2004       Impact factor: 5.366

10.  Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch.

Authors:  A Ikoma; M Fartasch; G Heyer; Y Miyachi; H Handwerker; M Schmelz
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

View more
  3 in total

Review 1.  [Pruritus and urticaria].

Authors:  U Raap; A Kapp; B Wedi; S Ständer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

Review 2.  [Chronic pruritus: principals of diagnostics and therapy].

Authors:  S Ständer
Journal:  Hautarzt       Date:  2007-07       Impact factor: 0.751

3.  [Pathogenesis of prurigo nodularis].

Authors:  U Raap; C Günther
Journal:  Hautarzt       Date:  2014-08       Impact factor: 1.198

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.